World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
37679
World Ranking
9585
National Ranking
528

Claudia Haferlach publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Claudia Haferlach sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 977 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Claudia Haferlach D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Claudia Haferlach sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Claudia Haferlach is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, with a focus on hematology. Their research encompasses a broad range of topics, with high activity in hematology, genetics, molecular biology, immunology, and oncology.

The scientist's work addresses several main topics in hematologic research:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Cancer Genomics and Diagnostics

Their frequent publication venues reflect the rheostat of their academic contributions, featuring prominent journals in their field:

  • Blood
  • Leukemia
  • HemaSphere
  • Blood Advances
  • Clinical Lymphoma Myeloma & Leukemia

Notable recent papers authored or co-authored by Claudia Haferlach include:

  • "Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma" (2021) published in Nature Medicine
  • "Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma" (2023) published in Nature Medicine
  • "Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms" (2020) published in Blood
  • "Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia" (2021) published in Cancer Discovery
  • "Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL" (2020) published in Blood

Their frequent co-authors include several researchers with substantial collaborative ties, highlighting the extent and integration of their work within the hematology research community:

  • Torsten Haferlach
  • Manja Meggendorfer
  • Wolfgang Kern
  • Wencke Walter
  • Stephan Hütter

Claudia Haferlach's research spans various subfields within medicine, predominantly focusing on hematology (with 172 publications), genetics (105 publications), molecular biology (64 publications), immunology (37 publications), and oncology (28 publications), reflecting a multidisciplinary approach to blood cancers and disorders.

Best Publications

  • Frequent pathway mutations of splicing machinery in myelodysplasia

    Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak

  • Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

    T Haferlach;Y Nagata;V Grossmann;Y Okuno

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

    Lisa J. Russell;Melania Capasso;Inga Vater;Takashi Akasaka

  • Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

    Yasunobu Nagata;Vera Grossmann;Yusuke Okuno;Ulrike Bacher

  • Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

    B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben

  • Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

    Ulrike Bacher;Claudia Haferlach;Wolfgang Kern;Torsten Haferlach

  • Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV H status and immunophenotyping

    C Haferlach;F Dicker;S Schnittger;W Kern

  • Minimal residual disease levels assessed by NPM1 mutation–specific RQ-PCR provide important prognostic information in AML

    Susanne Schnittger;Wolfgang Kern;Claudia Tschulik;Tamara Weiss

  • Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia

    Rüdiger Hehlmann;Michael Lauseker;Susanne Jung-Munkwitz;Armin Leitner

  • Dynamics of clonal evolution in myelodysplastic syndromes

    Hideki Makishima;Hideki Makishima;Tetsuichi Yoshizato;Kenichi Yoshida;Mikkael Sekeres

  • Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms

    Ayana Kon;Lee Yung Shih;Masashi Minamino;Masashi Sanada;Masashi Sanada

  • Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1

    Alexander Kohlmann;Vera Grossmann;Hans-Ulrich Klein;Sonja Schindela

  • Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit

    Hind Medyouf;Maximilian Mossner;Johann Christoph Jann;Florian Nolte

  • Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group

    Thomas Büchner;Wolfgang E. Berdel;Claudia Haferlach;Torsten Haferlach

  • Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV

    Rüdiger Hehlmann;Martin C. Müller;Michael Lauseker;Benjamin Hanfstein

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients

    S Jeromin;S Weissmann;C Haferlach;F Dicker

  • IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

    Susanne Schnittger;Claudia Haferlach;Madlen Ulke;Tamara Alpermann

  • Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia

    Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak

Frequent Co-Authors

Wolfgang Kern
Wolfgang Kern Munich Leukemia Laboratory (Germany)
Torsten Haferlach
Torsten Haferlach MLL Munich Leukemia Laboratory
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Seishi Ogawa
Seishi Ogawa Kyoto University
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Andreas Reiter
Andreas Reiter Heidelberg University
Martin Dugas
Martin Dugas Heidelberg University
Stefan W. Krause
Stefan W. Krause University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering Medicine in the USA, a range of online degrees offers flexible, accelerated routes to rewarding health careers. Programs such as the fastest msn to dnp program appeal to registered nurses seeking a quick transition into advanced practice or leadership roles. These options allow working professionals to balance their studies with other commitments.

If you desire a smoother academic journey, easiest online dnp programs offer pathways focused on student support and streamlined curricula. At a more entry-level, those looking to join the healthcare workforce soon can consider fast track lpn programs, which enable a faster start in practical nursing.

For nurses interested in mental health, enrolling in the psych np programs can help qualify for specialized roles as Psychiatric Mental Health Nurse Practitioners. Overall, these online pathways efficiently prepare students for in-demand medical and nursing careers across the United States.

Best Scientists Citing Claudia Haferlach

Trending Scientists

Recently Published Articles